Describes the ability of a series of endocrine-derived compounds, i. e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.
Inhaltsverzeichnis
LHRH/Somatostatin. - Chapter1 Twenty-five Years of Endocrine Oncology with Analogs of Hypothalamic Peptides: an Overview. - Chapter2 Analogs of Luteinizing Hormone-releasing Hormone in Benign Prostatic Hyperplasia and Advanced Renal Cell Carcinoma. - Chapter3 Luteinizing Hormone-releasing Hormone Antagonists in Gynecology. - Chapter4 Physiology and Pharmacology of Somatostatin and Its Receptors. - Chapter5 Investigation of LHRH Receptor Involvement in Melanoma Growth and Progression. - Somatostatin/GHRH/GH. - Chapter6 Cortistatin: Not Simply a Natural Somatostatin Analogue. - Chapter7 Antineoplastic and Antiangiogenic Actions of Somatostatin Analogs. - Chapter8 Somatostatin in Clinical Endocrinology. - Chapter9 Antagonists of Growth Hormone-releasing Hormone in Oncology. - Chapter10 GH Receptor Antagonists: Basic Knowledge and Clinical Perspectives. - Ghrelin and Ghrelin Mimetics (GHS). - Chapter11 Hypothalamic Circuits Responsive to Ghrelin: Regulation by Leptin and Insulin. - Chapter12 Physiological Function of Growth Hormone Secretagogue Receptors in the Cardiovascular System. - Chapter13 Endocrine and Extraendocrine Activity of Ghrelin and the GHS: Basic Research. - Chapter14 Endocrine and Nonendocrine Actions of Ghrelin and GHS: State of the Art in Clinical Research. - Hormonal Treatments for Endocrine-Dependent Tumors. - Chapter15 Hormonal Treatments of Endocrine-Dependent Tumors: Preclinical Aspects. - Chapter16 Hormonal Treatment of Endocrine-Dependent Tumors: Clinical Considerations. - Chapter17 Letrozole in the Treatment of Advanced Breast Cancer.